Skip to main content

Market Overview

36 Healthcare Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

  • Helius Medical Tech, Inc. (NASDAQ: HSDT) stock increased by 88.1% to $0.79 during Thursday's pre-market session. The market cap stands at $15.6 million.
  • Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) shares moved upwards by 41.7% to $4.18. The market cap stands at $102.6 million.
  • Catalyst Biosciences, Inc. (NASDAQ: CBIO) shares surged 27.9% to $6.10. The market cap seems to be at $65.5 million.
  • Rite Aid, Inc. (NYSE: RAD) stock surged 26.9% to $10.60. The market cap stands at $504.8 million.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) shares increased by 10.8% to $1.13. The market cap stands at $20.9 million.
  • Selecta Biosciences, Inc. (NASDAQ: SELB) shares increased by 8.9% to $1.59. The market value of their outstanding shares is at $70.8 million.
  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares rose 8.7% to $0.36. The market cap seems to be at $31.0 million.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) stock increased by 8.0% to $2.84. The market cap stands at $210.9 million. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) stock moved upwards by 8.0% to $96.70. The market cap stands at $1.3 billion. The most recent rating by Cantor Fitzgerald, on December 16, is at Overweight, with a price target of $104.00.
  • Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) stock increased by 6.5% to $0.31. The market cap stands at $64.8 million.
  • ObsEva, Inc. (NASDAQ: OBSV) shares increased by 6.4% to $3.16. The market cap seems to be at $337.6 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $40.00.
  • TherapeuticsMD, Inc. (NASDAQ: TXMD) shares surged 5.4% to $2.44. The market cap seems to be at $721.1 million.
  • Karuna Therapeutics, Inc. (NASDAQ: KRTX) stock increased by 4.9% to $69.25. The market cap stands at $1.6 billion. The most recent rating by Stifel Nicolaus, on December 19, is at Buy, with a price target of $126.00.
  • Genfit, Inc. (NASDAQ: GNFT) shares increased by 4.9% to $17.61. The market value of their outstanding shares is at $552.9 million.
  • Moleculin Biotech, Inc. (NASDAQ: MBRX) stock rose 3.8% to $0.99. The market value of their outstanding shares is at $48.9 million. The most recent rating by Oppenheimer, on October 17, is at Outperform, with a price target of $2.00.
  • Seattle Genetics, Inc. (NASDAQ: SGEN) stock rose 3.8% to $117.04. The market cap seems to be at $18.4 billion. The most recent rating by Oppenheimer, on December 12, is at Outperform, with a price target of $124.00.
  • Fortress Biotech, Inc. (NASDAQ: FBIO) stock rose 3.7% to $2.25. The market cap stands at $99.1 million. The most recent rating by B. Riley, on December 18, is at Buy, with a price target of $9.00.
  • Macrogenics, Inc. (NASDAQ: MGNX) stock increased by 3.5% to $10.95. The market cap seems to be at $463.2 million. The most recent rating by Cantor Fitzgerald, on December 19, is at Overweight, with a price target of $17.00.
  • Biocept, Inc. (NASDAQ: BIOC) shares rose 2.9% to $0.24. The market cap seems to be at $16.4 million.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares increased by 2.6% to $1.59. The market cap stands at $6.8 million.
  • Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) stock moved upwards by 2.5% to $3.76. The market value of their outstanding shares is at $114.4 million. The most recent rating by Cantor Fitzgerald, on December 17, is at Neutral, with a price target of $7.00.
  • Epizyme, Inc. (NASDAQ: EPZM) stock moved upwards by 2.0% to $20.50. The market cap stands at $1.0 billion. The most recent rating by Morgan Stanley, on December 06, is at Overweight, with a price target of $22.00.
  • Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares moved upwards by 1.7% to $1.17. The market cap seems to be at $46.0 million.
  • Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) shares moved upwards by 1.6% to $24.15. The market value of their outstanding shares is at $165.0 million.
  • Abeona Therapeutics, Inc. (NASDAQ: ABEO) stock surged 1.5% to $4.00. The market value of their outstanding shares is at $120.9 million.

 

Losers

  • Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) shares decreased by 25.9% to $0.40 during Thursday's pre-market session. The market value of their outstanding shares is at $43.0 million. The most recent rating by H.C. Wainwright, on October 28, is at Buy, with a price target of $1.20.
  • Minerva Neurosciences, Inc. (NASDAQ: NERV) stock plummeted 18.3% to $5.63. The market value of their outstanding shares is at $184.9 million. The most recent rating by H.C. Wainwright, on December 19, is at Buy, with a price target of $20.00.
  • Zafgen, Inc. (NASDAQ: ZFGN) stock fell 5.3% to $0.68. The market cap seems to be at $27.6 million.
  • Amarin Corp, Inc. (NASDAQ: AMRN) shares decreased by 2.5% to $20.30. The market cap stands at $5.8 billion. The most recent rating by Stifel, on December 16, is at Hold, with a price target of $26.00.
  • Ocugen, Inc. (NASDAQ: OCGN) shares declined 2.3% to $0.38. The market value of their outstanding shares is at $19.7 million. The most recent rating by Chardan Capital, on November 27, is at Buy, with a price target of $2.00.
  • Exicure, Inc. (NASDAQ: XCUR) shares plummeted 2.0% to $2.90. The market value of their outstanding shares is at $256.8 million. The most recent rating by Guggenheim, on November 20, is at Buy, with a price target of $9.00.
  • Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) stock fell 1.8% to $0.39. The market cap stands at $3.9 million. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
  • Solid Biosciences, Inc. (NASDAQ: SLDB) shares plummeted 1.6% to $3.90. The market cap seems to be at $508.2 million. The most recent rating by Nomura, on December 18, is at Buy, with a price target of $10.00.
  • Obalon Therapeutics, Inc. (NASDAQ: OBLN) stock plummeted 1.6% to $1.88. The market cap stands at $12.9 million.
  • Sesen Bio, Inc. (NASDAQ: SESN) shares plummeted 1.4% to $0.91. The market value of their outstanding shares is at $123.5 million.
  • Sanofi, Inc. (NASDAQ: SNY) shares decreased by 1.1% to $49.79. The market cap stands at $115.4 billion. According to the most recent rating by Barclays, on December 06, the current rating is at Underweight.
 

Related Articles (ADMS + ABEO)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com